Noramco is a specialty API CDMO that supports the advancement of opioid and non-opioid products. Headquartered in Delaware, Noramco maintains global facilities and supply chain networks for the farming, extraction, and production of controlled substances and opiate-derived APIs. Noramco has four decades of experience working in natural and synthetic APIs, and they provide clients with direct access to raw materials, proprietary platforms for API manufacture, a robust portfolio of controlled substance APIs, and FDA-audited and GMP-compliant manufacturing of controlled substances schedule I to schedule III.